Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High frequency of functionally active Melan-a-specific T cells in a patient with progressive immunoproteasome-deficient melanoma.

Cancer research - 1 Sept 2004

Meidenbauer Norbert, Zippelius Alfred, Pittet Mikaël J, Laumer Monika, Vogl Sandra, Heymann Jana, Rehli Michael, Seliger Barbara, Schwarz Stephan, Le Gal Frederique-Anne, Dietrich Pierre Y, Andreesen Reinhard, Romero Pedro, Mackensen Andreas

Abstract excerpt

Tumor-reactive T cells play an important role in cancer immunosurveillance. Applying the multimer technology, we report here an unexpected high frequency of Melan-A-specific CTLs in a melanoma patient with progressive lymph node metastases, consisting of 18 and 12.8% of total peripheral blood and tumor-infiltrating CD8+ T cells, respectively. Melan-A-specific CTLs revealed a high cytolytic activity against...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Cysteine Endopeptidases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HLA-A2 Antigen

Share to Lymph Nodes

Share to Melanoma

Share to Multienzyme Complexes

Share to Proteasome Endopeptidase Complex

Share to T-Lymphocytes, Cytotoxic

Source

Identifiers

PMID: 15342421
DOI: 10.1158/0008-5472.CAN-04-1341

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High frequency of functionally active Melan-a-specific T cells in a patient with progressive immunoproteasome-deficient melanoma.PMID 15342421Read ↗

Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients.Semantic proximity Read ↗

Evolution and modulation of antigen-specific T cell responses in melanoma patientsSemantic proximity Read ↗

Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patientsSemantic proximity Read ↗

HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.Semantic proximity Read ↗

Identification of two Melan-A CD4+ T cell epitopes presented by frequently expressed MHC class II alleles.Semantic proximity Read ↗

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.Semantic proximity Read ↗

Identification of non-mutated neoantigens presented by TAP-deficient tumorsSemantic proximity Read ↗

Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway.Semantic proximity Read ↗

Cancer immunoediting by melanocyte differentiation antigen-specific T cells determines response to immune checkpoint inhibitionSemantic proximity Read ↗

Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide.Semantic proximity Read ↗

Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model.Semantic proximity Read ↗

Resistance to checkpoint blockade therapy through inactivation of antigen presentationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.